肺浸潤性黏液腺癌一例_Chinese Journal of Respiratory and Critical Care Medicine

Authors：

夏俊杰 ¹ , 鄒興雄 ² ,  黃玲 ¹ , 邱宇 ¹ , 弋可 ¹ , 劉艷群 ¹ , 楊明 ¹

1. ;
2. ;

Corresponding?author：

黃玲, Email: huangling_tt@163.com

Keywords：

DOI：

10.7507/1671-6205.201807067

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 夏俊杰, 鄒興雄, 黃玲, 邱宇, 弋可, 劉艷群, 楊明. 肺浸潤性黏液腺癌一例. Chinese Journal of Respiratory and Critical Care Medicine, 2019, 18(1): 85-87. doi: 10.7507/1671-6205.201807067 Copy

1.	Chu PG, Chung L, Weiss LM, et al. Determining the site of origin of mucinous adenocarcinoma: An immunohistochemical study of 175 cases. Am J Surg Pathol, 2011, 35(12): 1830-1836.
2.	Chu PG, Schwarz RE, Lau SK, et al. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2. Am J Surg Pathol, 2005, 29(3): 359-367.
3.	Righi L, Vatrano S, Di NF, et al. Retrospective multicentre study investigating the role of targeted next-generation sequencing of selected cancer genes in mucinous adenocarcinoma of the lung. J Thorac Oncol, 2016, 11(4): 504-515.
4.	Turut H, Demirag F, Gulhan E, et al. Primary pulmonary mucin- ous adenocarcinoma in a 15-year-old boy. Eur J Cardiothorac Surg, 2006, 29(5): 851-853.
5.	Gaeta M, Blandino A, Pergolizzi S. Patterns of recurrence of bronchioloalveolar cell carcinomal after surgical resection: a radiological histological, and immunohistochemical study. Lung cancer, 2003, 42(3): 319-326.
6.	Inamura K, Ninomiya H, Ishikawa Y, et al. Is the epidermal growth factor receptor status in lung cancers reflected in clinicopathologic features. Arch Pathol Lab Med, 2010, 134(1): 66-72.
7.	Crino L, Kim D, Riely GJ. Initial phase II results with crizotinib in advanced ALK-positive non-small cell lung cancer (NSCLC): PROFILE 1005. J Clin Oncol, 2011, 29(Suppl): abstract 7514.
8.	趙瑞英, 張杰, 朱蕾, 等. 肺腺癌 7371 例間變性淋巴瘤激酶融合蛋白表達及其臨床病理特征分析. 中華病理學雜志, 2016, 45(9): 601-605.
9.	Kadota K, Yeh YC, D'Angelo SP, et al. Associations between mutations and histologic patterns of mucin in lung adenocarcinoma: invasive mucinous pattern and extracellular mucin are associated with KRAS mutation. Am J Surg Pathol, 2014, 38(8): 1118-1127.
10.	Boland JM, Maleszewski JJ, Wampfler JA, et al. Pulmonary invasive mucinous adenocarcinoma and mixed invasive mucinous/nonmucinous adenocarcinoma-a clinicopathological and molecular genetic study with survival analysis. Hum Pathol, 2018, 71: 8-19.
11.	Hwang DH, Sholl LM, Rojas-Rudilla V, et al. KRAS and NKX2-1 mutations in invasive mucinous adenocarcinoma of the lung. J Thorac Oncol, 2016, 11(4): 496-503.

1. Chu PG, Chung L, Weiss LM, et al. Determining the site of origin of mucinous adenocarcinoma: An immunohistochemical study of 175 cases. Am J Surg Pathol, 2011, 35(12): 1830-1836.
2. Chu PG, Schwarz RE, Lau SK, et al. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2. Am J Surg Pathol, 2005, 29(3): 359-367.
3. Righi L, Vatrano S, Di NF, et al. Retrospective multicentre study investigating the role of targeted next-generation sequencing of selected cancer genes in mucinous adenocarcinoma of the lung. J Thorac Oncol, 2016, 11(4): 504-515.
4. Turut H, Demirag F, Gulhan E, et al. Primary pulmonary mucin- ous adenocarcinoma in a 15-year-old boy. Eur J Cardiothorac Surg, 2006, 29(5): 851-853.
5. Gaeta M, Blandino A, Pergolizzi S. Patterns of recurrence of bronchioloalveolar cell carcinomal after surgical resection: a radiological histological, and immunohistochemical study. Lung cancer, 2003, 42(3): 319-326.
6. Inamura K, Ninomiya H, Ishikawa Y, et al. Is the epidermal growth factor receptor status in lung cancers reflected in clinicopathologic features. Arch Pathol Lab Med, 2010, 134(1): 66-72.
7. Crino L, Kim D, Riely GJ. Initial phase II results with crizotinib in advanced ALK-positive non-small cell lung cancer (NSCLC): PROFILE 1005. J Clin Oncol, 2011, 29(Suppl): abstract 7514.
8. 趙瑞英, 張杰, 朱蕾, 等. 肺腺癌 7371 例間變性淋巴瘤激酶融合蛋白表達及其臨床病理特征分析. 中華病理學雜志, 2016, 45(9): 601-605.
9. Kadota K, Yeh YC, D'Angelo SP, et al. Associations between mutations and histologic patterns of mucin in lung adenocarcinoma: invasive mucinous pattern and extracellular mucin are associated with KRAS mutation. Am J Surg Pathol, 2014, 38(8): 1118-1127.
10. Boland JM, Maleszewski JJ, Wampfler JA, et al. Pulmonary invasive mucinous adenocarcinoma and mixed invasive mucinous/nonmucinous adenocarcinoma-a clinicopathological and molecular genetic study with survival analysis. Hum Pathol, 2018, 71: 8-19.
11. Hwang DH, Sholl LM, Rojas-Rudilla V, et al. KRAS and NKX2-1 mutations in invasive mucinous adenocarcinoma of the lung. J Thorac Oncol, 2016, 11(4): 496-503.

Previous Article
淋巴管肌瘤病二例
Next Article
慢性阻塞性肺疾病的發病機制研究進展

Chinese Journal of Respiratory and Critical Care Medicine

肺浸潤性黏液腺癌一例

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content